nonrenal

nonrenal clearance accounts for approximately 30% of total drug elimination in elderly patients.

the nonrenal route of drug excretion becomes increasingly important when kidney function declines.

nonrenal loss of electrolytes can occur through excessive sweating or gastrointestinal disturbances.

studies show that nonrenal factors significantly influence drug disposition in critically ill patients.

nonrenal origin of ascites should be considered when hepatic function tests are normal.

the nonrenal elimination pathway compensates for reduced kidney function in some medications.

nonrenal causes of hyperkalemia include tissue breakdown and metabolic acidosis.

clinicians must evaluate nonrenal complications when prescribing nephrotoxic agents.

nonrenal absorption of nutrients occurs primarily in the small intestine.

age-related changes in nonrenal drug clearance require dose adjustment in geriatric populations.

the patient exhibited nonrenal symptoms suggesting an alternative diagnosis.

nonrenal metabolism of this compound primarily occurs in the liver.